FDA proposes rule to make many hearing aids cheaper
Reuters
Published Oct 19, 2021 09:43AM ET
Updated Oct 19, 2021 03:35PM ET
(Reuters) - The U.S. Food and Drug Administration on Tuesday proposed creation of a new category of over-the-counter (OTC) hearing aids to be sold directly to millions of Americans in an effort to make the devices more affordable.
White House spokeswoman Jen Psaki said the proposed rules should be finalized next year and should increase competition to drive down prices, so the devices cost "hundreds instead of thousands of dollars."
The changes "will help millions of Americans with mild to moderate healing loss get access to cheaper and more convenient access to hearing aids," she told reporters, adding just one-fifth of the estimated 37.5 million Americans who have trouble hearing use such aids.
The rule allows greater reach to communities of color that have been typically lacked access to hearing aids, said Xavier Becerra, secretary of Health and Human Services.
Under the proposal, hearing aids for severe hearing loss or for users younger than 18 would remain as prescription devices.
The department will take comments on the proposed rule for 90 days and plan to implement the rule 60 days after finalizing it.
"Finalizing this remains a top priority for the agency," said Jeff Shuren, director of the FDA's Center for Devices and Radiological Health, said during a press call.
Representative Debbie Dingell called the announcement "a major step forward for hearing health and will increase the accessibility of affordable hearing aid options for those who need them."
The proposed rule follows an instruction in President Joe Biden's broad competition executive order, which had told the Department of Health and Human Services to "promote the wide availability of low-cost hearing aids," among many other instructions aimed at a wide variety of industries.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.